Tesamorelin Dosing Protocol: 20 mg Vial — 10-Day Supply Guide
High-volume tesamorelin supply from the 20 mg vial — provides 10 daily doses at the FDA-approved 2 mg/day rate, minimizing reconstitution frequency.
Quickstart highlights
Tesamorelin at 2 mg/day over 26 weeks produces the highest-evidence visceral fat reduction of any GHRH analogue (15.2% in Phase 3, NCT00311948 / Falutz 2010).
- Concentration: 2 mg/mL (20 mg vial + 10 mL bacteriostatic water).
- At 2 mg/mL: 2 mg = 100 units (1 mL) once daily — FDA-approved Egrifta SV dose.
- One 20 mg vial provides exactly 10 daily doses at 2 mg; reconstitute every 10 days.
- Phase 3 (NCT00311948): 2 mg/day x 26 weeks — 15.2% visceral fat reduction vs. 0.7% placebo.
- Requires 10 mL bac water per reconstitution — use a 10 mL syringe or four 2.5 mL additions.
Dosing table
For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.
| Week | Dose (µg) | Units | Frequency | Notes |
|---|---|---|---|---|
| 1-4 | 1000 | 50 | Once daily | 1 mg — 50 units; 20 vial provides 20 doses at this level (20 days) |
| 5-26 | 2000 | 100 | Once daily | 2 mg — 100 units (FDA-approved dose); 20 mg vial provides 10 daily doses (10 days per reconstitution) |
Reconstitution steps
- Draw 10 mL bacteriostatic water (use four 2.5 mL draws from a 3 mL syringe, or a 10 mL syringe) into the vial.
- Inject slowly down the vial wall in divided portions to minimize foaming.
- Swirl gently between additions; allow to fully dissolve before drawing doses.
- Final concentration: 2 mg/mL (20 mg / 10 mL). Label with date; refrigerate at 2–8 °C. Use within 28 days.
Supplies needed
12-week plan
- 6 vials
- 84 syringes
- 60 mL bac water
- 84 alcohol swabs
26-week plan
- 19 vials
- 182 syringes
- 190 mL bac water
- 182 alcohol swabs
Protocol overview & cycle notes
Optimize 26-week tesamorelin protocol logistics by using the 20 mg vial — reducing reconstitution events to every 10 days versus every 2.5–5 days with smaller vials, improving sterility management and convenience.
Cycle length: 26 weeks on.
Off-cycle: 8 weeks off; measure IGF-1 and waist circumference before resuming.
Storage & handling
Injection & tracking tips
- Reconstituting 20 mg requires 10 mL bac water — use a 10 mL syringe or four sequential 2.5 mL additions.
- The 20 mg vial at 2 mg/day requires reconstitution every 10 days — reducing handling events to ~78 reconstitutions for a full 26-week protocol versus 182 with 5 mg vials.
- Mark each dose draw on the vial label to track remaining volume.
Tracking
Logging helps you and your provider spot patterns and adjust dose or timing.
- Measure waist circumference and weight weekly.
- Check IGF-1 at baseline, 8 weeks, and 16 weeks.
- Track fasting glucose and HbA1c every 8 weeks; GH elevation affects insulin sensitivity.
How this works & references
Sources
- Metabolic effects of a growth hormone-releasing factor in patients with HIV. Falutz J et al. — N Engl J Med — 2007
- FDA — Egrifta SV (tesamorelin) 2 mg/day prescribing information
- Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects. González-Sales M et al. — Clin Pharmacokinet — 2015
- Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension. Falutz J et al. — J Acquir Immune Defic Syndr — 2010
Frequently asked questions
How many 20 mg vials do I need for a 26-week protocol?
Is 10 mL too much bac water to add to one vial?
What is the shelf life concern when drawing 10 times from one vial?
Should I use a preservative-containing bac water?
Does the 20 mg vial require different storage than smaller vials?
Related protocols
Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide
Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.
View protocolVesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide
Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.
View protocolTestagen Dosing Protocol: 20 mg Vial — Testicular Bioregulator & Testosterone Support Guide
Testagen (Lys-Glu-Asp-Gly tetrapeptide) Russian testicular bioregulator dosing guide — Leydig cell gene normalization for testosterone production optimization and male reproductive aging support.
View protocolProstamax Dosing Protocol: 20 mg Vial — Prostate Bioregulator Guide
Prostamax (Lys-Asp-Glu-Leu tetrapeptide) Russian prostate bioregulator dosing guide — prostatic epithelial gene normalization for BPH, prostate aging, and urinary symptom support.
View protocolThis content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.